Neuronetics announces new publication in JAACAP on depressed adolescents

Neuronetics (STIM) announced the publication of significant real-world findings in the Journal of the American Academy of Child & Adolescent Psychiatry Open, JAACAP Open, a leading peer-reviewed medical journal covering pediatric psychiatry. The study found strong antidepressant treatment effects in adolescent and young adult patients treated with NeuroStar TMS. The results in these adolescent and young adult patients were consistent with those previously reported in adults. In a sample of 1,283 patients comprised of 682 patients aged 12-19 and 601 patients aged 20-21, approximately 70% of patients reported positive clinically meaningful improvement, and less than one percent reported clinically meaningful worsening, as measured by the Patient Health Questionnaire-9. The trajectory of improvement was similar to results from the adult populations, which showed a robust correlation between the sessions completed and the clinical improvement in depression symptoms, reaffirming the importance of completing a full treatment course to maximize treatment benefits.